Literature DB >> 12472542

Psoriasis bullosa acquisita.

S D Morris1, R Mallipeddi, N Oyama, M J Gratian, K E Harman, B S Bhogal, M M Black, R A J Eady, T Hashimoto, J A McGrath.   

Abstract

We report a 51-year-old man with a 20-year history of chronic plaque psoriasis who developed an autoimmune subepidermal blistering eruption that had clinical features of bullous pemphigoid, erythema multiforme and epidermolysis bullosa acquisita. Investigations revealed a 1 : 400 titre circulating and in vivo bound IgG autoantibody that mapped to the dermal side of 1 m NaCl-split skin and localized to the lower lamina lucida/upper lamina densa on immunogold electron microscopy. Immunoblotting, using dermal extracts, showed serum binding to antigens of approximately 200- and approximately 260 kDa. Indirect immunofluorescence microscopy, using the patient's serum on archival skin sections taken from selected individuals with different forms of inherited epidermolysis bullosa as substrate, showed normal basement membrane labelling on all samples apart from recessive dystrophic epidermolysis bullosa skin (with inherent mutations in the type VII collagen gene): in these cases there was a complete absence of immunostaining. Clinically, the patient responded rapidly to combination treatment with intravenous immunoglobulin and oral corticosteroids, dapsone and mycophenolate mofetil. Autoimmune subepidermal blistering has been reported in other patients with psoriasis, although no specific target antigen has ever been determined. Our study provides preliminary evidence that, for this patient at least, the autoantibody may be targeted against a skin component closely associated with type VII collagen (the epidermolysis bullosa acquisita antigen). Therefore, we propose the term 'psoriasis bullosa acquisita' for this and possibly other patients with similar skin eruptions.

Entities:  

Mesh:

Year:  2002        PMID: 12472542     DOI: 10.1046/j.1365-2230.2002.01100.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  Photoletter to the editor: Psoriatic erythroderma associated with bullous pemphigoid: clinical appearance and histopathology.

Authors:  Cristina Garrido Colmenero; Salvador Arias Santiago; Gonzalo Blasco Morente; Israel Pérez López; José Aneiros Fernández
Journal:  J Dermatol Case Rep       Date:  2015-03-31

2.  Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita.

Authors:  Ralf J Ludwig
Journal:  ISRN Dermatol       Date:  2013-07-15

3.  Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson's disease is more relevant to bullous pemphigoid.

Authors:  Paweł Bartkiewicz; Justyna Gornowicz-Porowska; Paweł P Pietkiewicz; Anna Świrkowicz; Monika Bowszyc-Dmochowska; Marian Dmochowski
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

Review 4.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

5.  Anti-p200 Pemphigoid: A Systematic Review.

Authors:  Khalaf Kridin; A Razzaque Ahmed
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

6.  Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.

Authors:  Ying-Han Xie; Si-Hang Wang; Si-Zhe Li; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

7.  Coexistence of psoriasis with bullous pemphigoid.

Authors:  Raghavendra Rao; Akash Gupta; Fousiya Yunis; Sripathi Handettu; Balachandran Chandrashekar
Journal:  Indian Dermatol Online J       Date:  2012-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.